Study Summary
This trial is testing whether it's safe to stop maintenance therapy for multiple myeloma patients who have had a stem cell transplant and are in remission.
- Multiple Myeloma
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
0 Primary · 6 Secondary · Reporting Duration: 3 years
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
0 Treatment Group
50 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · Phase 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Has this treatment earned the stamp of approval from the FDA?
"Our team at Power cautiously rated the safety of this treatment as a 1 because it is currently in Phase 1 trials, which implies there are limited findings to support its efficacy and safety." - Anonymous Online Contributor
Are there vacancies for participants in this scientific research endeavor?
"According to the clinicaltrials.gov database, recruitment for this medical trial is still ongoing. This research was initially posted on December 31st 2021 and recently updated on October 3rd 2022." - Anonymous Online Contributor
What is the sample size of individuals being observed in this clinical experiment?
"Affirmative. Data hosted on clinicaltrials.gov verifies that this medical experiment, which was first advertised on December 31st 2021, is currently recruiting participants. Approximately 50 patients must be enrolled from a single site." - Anonymous Online Contributor